Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
REDWOOD CITY, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Wednesday, October 30, 2024. Company management will host a conference call […]